$TVGN SEC Filings

Filed On	Filing
30 Sep 2026	8-K: Other Events Both previously disclosed Nasdaq compliance matters are now closed
16 Sep 2026	SCHEDULE 13D/A
16 Sep 2026	SCHEDULE 13D/A
16 Sep 2026	Form 4: Saadi Ryan H., Director Received 8,000,000 shares as a grant or award
16 Sep 2026	Form 4: Desai Kirti, Chief Financial Officer Received 750,000 shares as a grant or award
16 Sep 2026	8-K: Departure/Election of Directors or Officers; Compensation Tevogen Inc., a Delaware corporation (the “Company”), hereby grants shares of the Company’s common stock, par value $0.0001 per share (the “Stock”), to the Grantee named below, subject to the vesting conditions set forth below (such gran...
15 Sep 2026	Form 4: Goh Keow Lin, Director Received 75,000 shares as a grant or award
15 Sep 2026	Form 4: Podlogar Susan M, Director Received 75,000 shares as a grant or award
15 Sep 2026	Form 4: Sordillo Victor J., Director Received 75,000 shares as a grant or award
15 Sep 2026	Form 4: Feike Jeffrey L., Director Received 75,000 shares as a grant or award
15 Sep 2026	Form 4: Patton Curtis L., Director Received 75,000 shares as a grant or award
10 Sep 2026	8-K: Other Events On September 9, 2026, Tevogen Inc. (the “Company”) received written notice from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it had regained compliance with the $15 million minimum market value of publicly held share...
26 Aug 2026	8-K: Departure/Election of Directors or Officers; Compensation; Amendments to Articles/Bylaws; Change in Fiscal Year +1 more
24 Aug 2026	S-8
14 Aug 2026	10-Q
03 Aug 2026	Proxy statement: annual meeting on August 24, 2026
30 Jul 2026	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year
23 Jul 2026	PRE 14A
14 Jul 2026	SCHEDULE 13D/A
10 Jul 2026	Form 4: Sordillo Victor J., Director Received 40,000 shares as a grant or award

Comments